GLP-1 Drugs Tied to Lower Risk of Legal Blindness in People With Diabetes

(MedPage Today) — ORLANDO — Adding another twist to the ongoing debate over the effects of weight-loss drugs on vision, a retrospective cohort study has linked GLP-1 receptor agonists to a lower risk of legal blindness in patients with type 2…